Companies by Sector - Pharmaceuticals and Biotechnology
| EPIC | Company | Index | Dividend Yield | Market Cap | Price Close | % Change |
|---|---|---|---|---|---|---|
| AZN | AstraZeneca | FTSE 100 | 1.79 | £204.73B | 13,284.00 | 0.64% |
| GSK | GSK | FTSE 100 | 3.68 | £79.27B | 1,950.00 | -0.41% |
| HLN | Haleon | FTSE 100 | 2.12 | £29.59B | 333.30 | -0.54% |
| HIK | Hikma Pharmaceuticals | FTSE 100 | 4.23 | £3.14B | 1,467.00 | 0.00% |
| INDV | Indivior | FTSE 250 | £1.54B | 1,238.00 | -3.10% | |
| GNS | Genus | FTSE 250 | 1.47 | £1.45B | 2,216.00 | 1.74% |
| HCM | Hutchmed China | AIM | £1.38B | 156.00 | 4.80% | |
| OXB | Oxford BioMedica | FTSE Small Cap | £730.9M | 601.00 | -0.50% | |
| AGY | Allergy Therapeutics | AIM | £500.27M | 7.50 | -2.50% | |
| AVCT | Avacta Group | AIM | £332.51M | 73.00 | -7.00% | |
| PRTC | Puretech Health | FTSE Small Cap | £319.36M | 129.60 | -1.22% | |
| SCLP | Scancell Holdings | AIM | £210.15M | 20.94 | -1.10% | |
| BTG | BTG | AIM | 3.62 | £195.93M | 122.00 | -0.10% |
| ANCR | Animalcare Group | AIM | 2.12 | £169.16M | 245.00 | -2.60% |
| MXCT | Maxcyte Inc | AIM | £161.75M | 147.69 | -1.20% | |
| BMK | Benchmark Holdings | AIM | £135.69M | 22.05 | 1.50% | |
| DXRX | Diaceutics | AIM | £120.66M | 142.50 | -0.50% | |
| ANP | Anpario | AIM | 2.40 | £106.18M | 520.00 | -0.90% |
| FARN | Faron Pharmaceuticals OY | AIM | £91.3M | 42.00 | 1.10% | |
| BVXP | Bioventix | AIM | 9.06 | £86.47M | 1,700.00 | -2.20% |
| 4BB | 4basebio | AIM | £81.58M | 525.00 | -0.40% | |
| OBI | Ondine Biomedical Inc | AIM | £76.63M | 15.00 | 2.60% | |
| STX | Shield Therapeutics | AIM | £68.38M | 6.30 | -7.90% | |
| ANIC | Agronomics | AIM | £63.39M | 6.01 | -0.60% | |
| EAH | Eco Animal Health Group | AIM | £62.34M | 92.00 | -4.30% | |
| HVO | Hvivo | AIM | 2.52 | £56.68M | 7.90 | -5.10% |
| POLB | Poolbeg Pharma | AIM | £53.59M | 7.88 | -2.10% | |
| ABDX | Abingdon Health | AIM | £52.01M | 11.57 | 2.60% | |
| SAR | Sareum Holdings | AIM | £31.87M | 23.40 | -5.60% | |
| IMM | ImmuPharma | AIM | £27.45M | 4.60 | -3.00% | |
| EDEN | Eden Research | AIM | £25.31M | 3.14 | -2.40% | |
| SBTX | SkinBioTherapeutics | AIM | £24.62M | 12.00 | -14.90% | |
| AREC | Arecor Therapeutics | AIM | £23.6M | 62.50 | -1.30% | |
| GDR | Genedrive | AIM | £19.27M | 1.20 | -1.60% | |
| IXI | Ixico | AIM | £19.08M | 8.53 | -1.50% | |
| CEL | Celadon Pharmaceuticals | AIM | £9.23M | 13.40 | % | |
| OBD | Oxford BioDynamics | AIM | £7.72M | 0.19 | -4.00% | |
| AGL | Angle | AIM | £7.72M | 2.40 | -0.70% | |
| OPTI | OptiBiotix Health | AIM | £6.4M | 6.20 | -3.30% | |
| VRCI | Verici Dx | AIM | £5.68M | 0.35 | -4.80% | |
| PRM | Proteome Sciences | AIM | £5.61M | 1.60 | 8.00% | |
| TRX | Tissue Regenix Group | AIM | £5.16M | 7.25 | -1.50% | |
| FUM | Futura Medical | AIM | £3.2M | 0.60 | 14.60% | |
| GUN | Gunsynd | AIM | £1.55M | 0.11 | 9.50% | |
| VAL | ValiRx | AIM | £1.42M | 0.18 | -2.20% |